A Life Science Accelerator
501 Ventures is a Life Science Accelerator Providing Turnkey Solutions for IP Based Technologies
501 Ventures is an umbrella organization providing investment opportunities in asset-based subsidiaries while providing capital efficiency of shared talent and overhead
The 501 Ventures Competitive Advantage
Track record of company and asset exits in the industry:
Leadership team has deep understanding of big pharma’s needs to drive efficiency
Proven track record managing small and lean start-ups:
Search team performs extensive due dilligence identifying high priority requirements needed to get assets to next inflection point.
Comprehensive in-house clinical development experts:
The majority of clinical development is done in house without use of CROs decreasing the time and financial resources needed.
Drug-Device Combination to Manage External Bleeding
Our team at 501 Ventures is comprised of entrepreneurs with executive leadership experience
- The shared model allows human capital and overhead to be distributed across 2-4 programs providing subsidiaries experienced talent and infrastructure at a fraction of the cost
- Capital raised in subsidiaries that have service arrangement with 501
- The majority of clinical work is done “in house” with minimal use of third party vendors providing time and financial savings